Korean Circ J.  2020 Aug;50(8):706-708. 10.4070/kcj.2020.0217.

Non-alcoholic Fatty Liver Disease, Cardio-metabolic Syndrome and Hypertension: One Concept Fits Multi-systemic Presentations

• Kim MJ

• KMID: 2505124
• DOI: http://doi.org/10.4070/kcj.2020.0217

Reference

1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120:1640–1645. PMID: 19805654.

2. Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75:525–538. PMID: 32029136.

3. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001; 50:1844–1850. PMID: 11473047.

4. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64:73–84. PMID: 26707365.

5. Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015; 148:547–555. PMID: 25461851.

6. Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT. Visceral and intrahepatic fat are associated with cardiometabolic risk factors above other ectopic fat depots: the Framingham Heart Study. Am J Med. 2018; 131:684–692.e12. PMID: 29518370.

7. Park J, Kim NH, Kim SH, et al. Visceral adiposity and skeletal muscle mass are independently and synergistically associated with left ventricular structure and function: the Korean Genome and Epidemiology Study. Int J Cardiol. 2014; 176:951–955. PMID: 25192782.

8. Deng G, Yin L, Liu W, et al. Associations of anthropometric adiposity indexes with hypertension risk: a systematic review and meta-analysis including PURE-China. Medicine (Baltimore). 2018; 97:e13262. PMID: 30508913.

9. Roh JH, Park JH, Lee H, et al. A close relationship between non-alcoholic fatty liver disease marker and new-onset hypertension in healthy Korean adults. Korean Circ J. 2020; 50:695–705.

10. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6:33. PMID: 17081293.

11. Bonnet F, Gastaldelli A, Pihan-Le Bars F, et al. Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies. J Hypertens. 2017; 35:493–500. PMID: 27984413.

12. Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-based chronic disease, addressing knowledge and clinical practice gaps: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75:539–555. PMID: 32029137.